Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

| More on:
A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

CSL Ltd (ASX: CSL)

According to a note out of Morgan Stanley, its analysts have initiated coverage on this biotechnology giant's shares with an overweight rating and $313.00 price target. Morgan Stanley has been looking at the healthcare sector and is seeing opportunities for investors. This follows an underperformance in the sector over the past 12 months. One of its top picks is CSL, which it highlights is trading at a discount to 10-year average multiples. The broker thinks this makes it a good time to buy, especially given its belief that CSL is well-placed to deliver strong earnings growth over the next three years thanks to margin expansion in the key CSL Behring business. The CSL share price ended the week at $254.00.

Gold Road Resources Ltd (ASX: GOR)

A note out of Bell Potter reveals that its analysts have retained their buy rating and $2.95 price target on this gold miner's shares. The broker notes that Gold Road's first quarter production is below expectations due to crusher maintenance and the failure of two conveyor belts. Although this is disappointing and the broker has reduced its production forecast slightly, this negative has been offset by an increase in its gold price assumptions. In addition, the broker remains positive on the company's outlook and feels it can still come close to reaching the middle of its guidance range in FY 2025. As a result, it feels that the company remains an attractive investment. Especially given strong spot gold prices and its growing unhedged gold production. The Gold Road share price was fetching $2.38 at Friday's close.

Qantas Airways Ltd (ASX: QAN)

Analysts at Goldman Sachs have retained their buy rating and $11.80 price target on this airline operator's shares. According to the note, Goldman highlights that Qantas' shares have fallen heavily this month. This has been driven by the release of disappointing trading updates from a number of US airlines. Goldman feels this this selling has been an overreaction, especially given how different the two markets are. It also reminds investors that Qantas provided an update of its own only a few weeks ago. And that update pointed to favourable trading conditions. Outside this, the broker continues to highlight that the Flying Kangaroo's earnings capacity has sustainably improved since COVID and justifies the significant re-rating in its share price. The Qantas share price ended the week at $9.02.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Goldman Sachs Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

Why Macquarie forecasts this ASX All Ords media company is set to surge 19%

Up 42% in 2025, here’s why this ASX All Ords media stock could keep racing higher into 2026.

Read more »

Excited couple celebrating success while looking at smartphone.
Broker Notes

Buy this ASX 200 stock for a 50% return: Bell Potter

Let's see why the broker is bullish on this name.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Leading broker tips 50%+ upside for IDP Education shares

The team at Macquarie thinks this beaten down stock could be a buy.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in June

The broker is feeling bullish on these names this month. Let's find out why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Bell Potter says this ASX 200 share can rise 25%

Let's see what the broker is saying about this stock.

Read more »

Stethoscope with a piggy bank in the middle.
Broker Notes

Australian health insurance: Does Macquarie prefer Medibank or NIB shares?

Medibank and NIB shares have both surged in 2025. Here’s what Macquarie expects now.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

9 ASX 200 shares just upgraded to strong buy ratings

Brokers have upgraded these shares amid expectations of price growth over the next 12 months.

Read more »